Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis - Report - MDSpire

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

  • By

  • Konstantinos Pamporis

  • Paschalis Karakasis

  • Marios Sagris

  • Panagiotis Theofilis

  • Nikias Milaras

  • Antonia Pantelidaki

  • Iordanis Mourouzis

  • Nikolaos Fragakis

  • Konstantinos Vlachos

  • Athanasios Kordalis

  • Dimitrios Tsiachris

  • March 7, 2025

  • 0 min

Share

Clinical Report: Prevalence and Risk Factors of Asymptomatic Atrial Fibrillation

Overview

This systematic review and meta-analysis found that approximately 27% of atrial fibrillation (AF) patients are asymptomatic. Key risk factors positively associated with asymptomatic AF include male sex, diabetes mellitus, chronic kidney disease, and prior stroke or transient ischemic attack, while heart failure is negatively associated.

Background

Atrial fibrillation is the most common cardiac arrhythmia, affecting about 2% of the general population and associated with increased morbidity and mortality. Symptoms of AF vary but many patients remain asymptomatic, complicating diagnosis and management. Asymptomatic AF patients share similar risks of adverse outcomes as symptomatic patients and may have a higher risk of disease progression. Current guidelines recommend screening in older adults, but screening practices do not specifically target asymptomatic individuals due to limited evidence.

Data Highlights

ParameterOdds Ratio (OR)95% Confidence IntervalP-valueI2 (%)
Prevalence of asymptomatic AF27%22% - 33%100
Male sex1.671.48 - 1.89<0.00185
Diabetes mellitus1.191.07 - 1.330.00287
Chronic kidney disease1.211.08 - 1.36<0.00180
Stroke/transient ischemic attack1.431.18 - 1.73<0.00195
Heart failure0.710.54 - 0.940.01797
Permanent AF2.131.28 - 3.550.00498
Catheter ablation0.630.44 - 0.910.01295
Beta-blockers0.900.82 - 0.980.01868
Antiarrhythmics0.530.35 - 0.790.00295

Key Findings

  • Approximately 27% of AF patients are asymptomatic, with prevalence varying by population risk factors.
  • Male sex is significantly associated with higher odds of asymptomatic AF (OR 1.67).
  • Diabetes mellitus, chronic kidney disease, and prior stroke or transient ischemic attack increase the likelihood of asymptomatic AF.
  • Heart failure is negatively associated with asymptomatic AF (OR 0.71), indicating symptomatic presentation is more common in these patients.
  • Permanent AF is positively associated with asymptomatic status, whereas interventions such as catheter ablation, beta-blockers, and antiarrhythmic drugs are negatively associated.
  • These associations are consistent regardless of symptom assessment methods, study design, or whether AF was incident or prevalent.

Clinical Implications

Given the high prevalence of asymptomatic AF and its association with specific risk factors, clinicians should consider targeted screening strategies in patients with diabetes, chronic kidney disease, prior stroke/TIA, and males. Early identification of asymptomatic AF may help prevent disease progression and adverse outcomes. Treatment and rhythm control interventions appear less common in asymptomatic patients, highlighting the need for awareness and appropriate management.

Conclusion

Asymptomatic AF affects over a quarter of AF patients and is linked to distinct clinical characteristics. Incorporating risk factor profiles into screening protocols may improve detection and management of this high-risk subgroup.

References

  1. Systematic Review and Meta-Analysis 2025 -- Frequency and Associated Risk Factors of Asymptomatic Atrial Fibrillation

Original Source(s)

Related Content